AnemiaNCT06066151
The Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome
A study testing Minayo Yeast Drink Product in people with Anemia and Skin Condition, run by Hangzhou Agile Groups Network Technology Co., Ltd. at 1 site in China.
Trial summary
The goal of this single arm, open-label study is to learn about the efficacy of Minayo Iron-rich Yeast Drink with SOD on females who are aged 18-35 and suffer nutritional Anemia, skin condition and Qi-blood deficiency syndrome. Read more about this study
- Who is it for?
- Ages 18 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Anemia, Skin Condition
- What is being tested?
- Minayo Yeast Drink Product
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 11 participants
- Where
- 1 siteChina
- Study dates
- 10 Sep 2023to 15 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Female, aged 18 to 35;
- Hemoglobin concentration level below 110g/L based on WHO diagnostic criteria for anemia;
- Agree not to take any drugs, supplements, or other dairy products during the trial;
- Agree not to take any other medications or supplements containing iron during the trial;
- Willing to refrain from participating in other interventional clinical studies during the trial period;
- Be able to fully understand the purpose, benefits and potential risks including side effects of the research;
- Willing to obey all test requirements and procedures;
- Informed consent signed.
Who cannot join
- Anemia caused by organic diseases;
- Subject who is in the treatment of gastrointestinal symptoms;
- Lactose intolerance;
- Subject who is currently presence of other organic diseases affecting intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
- Controlling diet, exercising, or taking medications to control weight or affect appetite in the last 3 months;
- Subject who has any of the following medical history or clinical findings that may affect the evaluation of the trial effect: significant gastrointestinal disorders, liver, kidney, endocrine, hematological, respiratory and cardiovascular diseases;
Show all 12Show fewer
- Abuse alcohol or other drugs, supplement or OTC drugs currently or n the past may cause bowel dysfunction or can affect test result evaluation;
- Frequently use of medications that may affect gastrointestinal function or the immune system according to investigator's judgment;
- Take laxatives or other substances that promote digestion 2 weeks before the trail start;
- Subject who used drugs or supplements of iron agent 10 days before the beginning of the trial;
- Pregnant or lactating women or those planning to become pregnant during the trial;
- PI deems that subjects could not fully cooperate with trial arrangements.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Single Arm, Open-label Study of the Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome
The goal of this single arm, open-label study is to learn about the efficacy of Minayo Iron-rich Yeast Drink with SOD on females who are aged 18-35 and suffer nutritional Anemia, skin condition and Qi-blood deficiency syndrome. The main question it aims to answer is:
- whether the serum ferritin level in blood is improved after the intervention
Read more
14 qualified participants will be enrolled to drink the product "Minayo Iron-rich Yeast Drink with SOD" for four weeks, once a day. Four site visits will be made for each participant so that all relevant clinical data will be captured and recorded for data analysis and reporting.
Researchers will compare the final blood test result (hemoglobin concentration level, Glutathione (GSH), Superoxide Dismutase (SOD)) against the baseline to conclude whether the product will be effective in improving Anemia and skin conditions.
- Conditions
- Anemia, Skin Condition
- Being tested
- Minayo Yeast Drink Product
- Keywords
- Minayo Iron-rich Yeast Drink, SOD, GSH
- Medical subject headings
- Anemia, Skin Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Minayo Yeast Drink ProductDietary supplement
Participants need to drink one piece of the products each day, for 4 consecutive weeks.
| Study group | Role | What they receive |
|---|---|---|
| Minayo Yeast Drink Product | Experimental | Minayo Iron-rich Yeast Drink with SOD, 385 pieces, 25ml/piece, each piece contains 13mg of iron.
Main ingredients: Water, erythritol, jujube juice concentrate, Wolfberry juice concentrate, ferrous gluconate, olive powder, SOD yeast powder, yeast extract (including glutathione), artichoke, etc. Receives: Dietary Supplement: Minayo Yeast Drink Product |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change of Serum Ferritin Level
The change of serum ferritin level in blood, ng/mL (12~135ng/mL for healthy female, 27~375ng/mL for healthy male)
Measured: baseline day, end of week 4
Secondary outcomes (4)
Hemoglobin Concentration Level
The change of hemoglobin concentration level in blood, g/L (115-150g/L)
Measured: baseline day, end of week 4
Superoxide Dismutase (SOD) Concentration Level
The change of Superoxide dismutase (SOD) concentration in blood, U/ml (1000~2000U/ml)
Measured: baseline day, end of week 4
Glutathione (GSH) Concentration Level
The change of Glutathione (GSH) concentration level in blood, mg/L (280~380mg/L)
Measured: baseline day, end of week 4
Skincare Measurement - Lines/Wrinkles
The changes of the lines/wrinkles on the face by Miravex Antera 3D imaging system
Measured: baseline day, end of week 4
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Oct 2023
- Study start10 Sep 2023
- Primary completion9 Oct 2023
- Study completion15 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnemiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 11 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hangzhou Agile Groups Network Technology Co., Ltd.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Charlie Zhang, MD, Principal investigator, Raison Biotech Co., Ltd.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06066151
- Sponsor's protocol ID
- 23-RD-09-MY-001
- Status last verified
- Sep 2025
- First submitted
- 27 Sep 2023
- Last updated
- 15 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Single Arm, Open-label Study of the Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome
- ClinicalTrials.gov ID
- NCT06066151
- Acronym / sponsor ID
- 23-RD-09-MY-001
- Conditions
- Anemia, Skin Condition
- Keywords
- Minayo Iron-rich Yeast Drink, SOD, GSH
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 11 participants (actual)
- Lead sponsor
- Hangzhou Agile Groups Network Technology Co., Ltd.Industry (pharma, biotech, devices)
- Study start
- 10 Sep 2023 (actual)
- Primary completion
- 9 Oct 2023 (actual)
- Study completion
- 15 Dec 2023 (actual)
- First posted
- 4 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this single arm, open-label study is to learn about the efficacy of Minayo Iron-rich Yeast Drink with SOD on females who are aged 18-35 and suffer nutritional Anemia, skin condition and Qi-blood deficiency syndrome. The main question it aims to answer is:
- whether the serum ferritin level in blood is improved after the intervention
14 qualified participants will be enrolled to drink the product "Minayo Iron-rich Yeast Drink with SOD" for four weeks, once a day. Four site visits will be made for each participant so that all relevant clinical data will be captured and recorded for data analysis and reporting.
Researchers will compare the final blood test result (hemoglobin concentration level, Glutathione (GSH), Superoxide Dismutase (SOD)) against the baseline to conclude whether the product will be effective in improving Anemia and skin conditions.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Minayo Yeast Drink Product | Experimental | Dietary Supplement: Minayo Yeast Drink ProductMinayo Iron-rich Yeast Drink with SOD, 385 pieces, 25ml/piece, each piece contains 13mg of iron. Main ingredients: Water, erythritol, jujube juice concentrate, Wolfberry juice concentrate, ferrous gluconate, olive powder, SOD yeast powder, yeast extract (including glutathione), artichoke, etc. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Female, aged 18 to 35;
- Hemoglobin concentration level below 110g/L based on WHO diagnostic criteria for anemia;
- Agree not to take any drugs, supplements, or other dairy products during the trial;
- Agree not to take any other medications or supplements containing iron during the trial;
- Willing to refrain from participating in other interventional clinical studies during the trial period;
Key exclusion criteria (12 listed)
- Anemia caused by organic diseases;
- Subject who is in the treatment of gastrointestinal symptoms;
- Lactose intolerance;
- Subject who is currently presence of other organic diseases affecting intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
- Controlling diet, exercising, or taking medications to control weight or affect appetite in the last 3 months;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Minayo Yeast Drink ProductParticipants need to drink one piece of the products each day, for 4 consecutive weeks. | Dietary supplement | Minayo Yeast Drink Product |
Primary outcome
Change of Serum Ferritin Level
Time frame: baseline day, end of week 4
The change of serum ferritin level in blood, ng/mL (12~135ng/mL for healthy female, 27~375ng/mL for healthy male)
4 secondary outcomes
Hemoglobin Concentration Level
Time frame: baseline day, end of week 4
Superoxide Dismutase (SOD) Concentration Level
Time frame: baseline day, end of week 4
Glutathione (GSH) Concentration Level
Time frame: baseline day, end of week 4
Skincare Measurement - Lines/Wrinkles
Time frame: baseline day, end of week 4
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Anemia
RecruitingPhase 1/2
The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia
Aplastic Anemia, Refractory
Active, not recruitingPhase 1
A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
Autoimmune Hemolytic Anemia, Anti-CD19 STAR T-cell Therapy
Not yet recruitingObservational study
Systematic Intraoperative Cell Salvage in On-Pump Cardiac Surgery Within a Mature Patient Blood Management Programme
Cardiac Surgical Procedures, Blood Transfusion
RecruitingPhase 1/2
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes
RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Charlie Zhang, MD principal investigator
Raison Biotech Co., Ltd.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Minayo Yeast Drink Product in people with Anemia and Skin Condition, run by Hangzhou Agile Groups Network Technology Co., Ltd. at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change of Serum Ferritin Level (time frame: baseline day, end of week 4). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2025.